Repositioning Candidate Details
| Candidate ID: | R1064 |
| Source ID: | DB06618 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | Cutamesine |
| Synonyms: | Cutamesine |
| Molecular Formula: | C23H32N2O2 |
| SMILES: | COC1=C(OC)C=C(CCN2CCN(CCCC3=CC=CC=C3)CC2)C=C1 |
| Structure: |
|
| DrugBank Description: | -- |
| CAS Number: | 165377-43-5 |
| Molecular Weight: | 368.521 |
| DrugBank Indication: | Investigated for use/treatment in strokes and depression. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | -- |
| Inclusion Criteria: | Indication associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I16 | 6713 | Cerebrovascular disease | An vascular disease that is characterized by dysfunction of the blood vessels supplying the brain. http://en.wikipedia.org/wiki/Cerebrovascular_disease, http://www.ncbi.nlm.nih.gov/books/NBK378/ | disease of anatomical entity/ cardiovascular system disease/ vascular disease/cerebrovascular disease | Details |
| I17 | 1596 | Mental depression | Mental depression | disease of mental health/ cognitive disorder/ mood disorder | Details |